Legend Biotech Cash from Financing (TTM) Trends

Legend Biotech Corp (LEGN)

45.41 -0.52 (-1.13%) USD | NASDAQ | May 03, 16:00

45.42 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2019. Upgrade now.

Date	Value
December 31, 2023	791.49M
September 30, 2023	789.78M
June 30, 2023	1.167B
March 31, 2023	377.66M
December 31, 2022	377.98M
September 30, 2022	702.32M
June 30, 2022	325.74M
March 31, 2022	626.48M
December 31, 2021	626.66M

Date	Value
September 30, 2021	303.76M
June 30, 2021	312.28M
March 31, 2021	470.33M
December 31, 2020	618.88M
September 30, 2020	611.54M
June 30, 2020	601.72M
March 31, 2020	134.74M
December 31, 2019	14.67M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

14.67M

Minimum

Dec 2019

1.167B

Maximum

Jun 2023

520.74M

Average

601.72M

Median

Jun 2020

Cash from Financing (TTM) Benchmarks